310
Participants
Start Date
January 31, 2014
Primary Completion Date
December 31, 2019
Study Completion Date
December 31, 2019
NC-6004
"Study group (3 week/cycle):~NC-6004 90 mg/m2 i.v. inf. over 60 min on Day 1"
Gemcitabine
"Study group (3 week/cycle):~Gemcitabine 1000 mg/m2 i.v. inf. over 30 min on Day 1 and Day 8 (follow by administration of NC-6004)~Control group (4 week/cycle):~Gemcitabine 1000 mg/m2 i.v. inf. over 30 min on Day 1, Day 8 and Day 15"
Mackay Memorial Hospital, Taipei
National Taiwan University Hospital, Taipei
Taipei Medical University Hospital, Taipei
Koo Foundation Sun Yat-Sen Cancer Center, Taipei
Taipei Veterans General Hospital, Taipei
Tri-Service General Hospital, Taipei
Taipei Medical University-Shuang-Ho Hospital, Ministry of Health and Welfare, Taipei
Chang Gung Memorial Hospital, Linkou Branch, Taipei
China Medical University Hospital, Taichung
National Cheng Kung University Hospital, Tainan City
Chi Mei Hospital, Tainan City
Chi Mei Medical Center, Yongkang District
Chang Gung Memorial Hospital, Kaohsiung Branch, Kaohsiung City
Makati Medical Center, Makati
Taichung Veterans General Hospital, Taichung
Chiayi Chang Gung Memorial Hospital, Chiayi City
Kaohsiung Medical University Hospital, Kaohsiung City
National Cancer Centre, Singapore
Prince of Wales Hospital, Hong Kong
Queen Mary Hospital, Hong Kong
Aichi Cancer Center, Aichi
Chiba Cancer Center, Chiba
National Hospital Organization Kyushu Cancer Center, Fukuoka
Hokkaido University Hospital, Hokkaido
National Hospital Organization Osaka National Hospital, Osaka
Osaka Medical Center for Cancer and Cardiovascular Diseases, Osaka
Saitama Cancer Center, Saitama
National Hospital Organization Shikoku Cancer Center, Shikokuchūō
Shizuoka Cancer Center, Shizuoka
Center Hospital of the National Center for Global Health and Medicine, Tokyo
Kyorin university Hospital, Tokyo
National Cancer Center Hospital East, Tokyo
National Cancer Center Hospital, Tokyo
The Cancer Institute Hospital of JFCR, Tokyo
The University of Tokyo Hospital, Tokyo
Kanagawa Cancer Center, Yokohama
Hospital Sultan Ismail, Johor Bahru
Hospital Kuala Lumpur, Kuala Lumpur
Ajou University Hospital (AUH), Gyeonggi-do
Samsung Medical Center (SMC), Seoul
The Catholic University of Korea, Seoul St. Mary's Hospital (CUK SSMH), Seoul
Korea University Guro Hospital (KUGH), Seoul
Yonsei University Health System, Severance Hospital, Seoul
NanoCarrier Co., Ltd.
INDUSTRY
Orient Europharma Co., Ltd.
INDUSTRY